Alvin Zapata

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

S. Ourselin, F. Barkhof, D. MacManus, 2020, The Lancet Neurology.